Singapore, March 28 -- Japan's Shin Nippon Biomedical Laboratories (SNBL) and Tasso, Inc., the Seattle-based leading provider of patient-centric, clinical grade blood collection solutions have agreed to establish a new joint venture (JV) company for exclusive distribution of Tasso's proprietary on-demand blood collection device in Japan.

The establishment of the JV between SNBL and Tasso aims to contribute to important themes in Japan, such as self-medication, preventative medicine, telemedicine, and reducing the burden on medical professionals (particularly doctors and nurses), by leveraging the unique features of Tasso's self-blood collection device: (1) it enables a painless collection, (2) it can be used anywhere, including at home, ...